Otros idiomas Lee's Pharmaceutical Holdings Limited

Acciones

950 KYG5438W1116

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:09:00 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1,18 ^HKD	+2,61 %		+9,26 %	-22,88 %

19/04	El beneficio de Lee's Pharmaceutical en 2023 cae un 67	MT
26/03	Lee's Pharmaceutical Holdings Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Lee’s Pharmaceutical's 2023 Profit Slumps 67%	19/04
Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024	26/03
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
China Grants Lee's Pharmaceutical Drug Registration for Schizophrenia-Related Agitation Treatment; Shares Rise 3%	29/11
Lee’s Pharmaceutical Sells Rights for Eyprotor to Zhaoke Ophthalmology for 60 Million Yuan	14/11
Lee's Pharmaceutical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 October 2023	30/08/23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Lee's Pharmaceutical Holdings Unit's Fentanyl Inhalable Reaches Endpoints in Phase 2A Trial	22/08/23
Lee's Pharmaceutical Holdings Limited Announces Phase IIa Clinical Trial of A F fentanyl Aerosol for Inhalation Conducted by Zhaoke Pharmaceutical Limited	21/08/23
Lee's Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023	21/08/23
Lee’s Pharmaceutical Gets Registration Certificate for Medical Device to Treat Hypoxic Respiratory Failure	09/06/23
Lee's Pharmaceutical Holdings Limited Appoints Cheang Yee Wah, Eva as Independent Non-Executive Director	17/05/23
Lee's Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 15 June 2023	30/03/23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Lee’s Pharmaceutical Holdings Warns of Plunge in 2022 Profit	21/03/23
Lee's Pharmaceutical Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	20/03/23
Extended Phase 2b Study for Lee's Pharmaceutical's Tafoxiparin Concludes; Shares Slip 3%	17/02/23
Nine Lee's Pharma Products Included in China's National Reimbursement Drug List	20/01/23
Lee's Pharmaceutical Holdings Limited Announces Inclusion of Treprostinil Injection, Teglutik and Trittico in the National Reimbursement Drug List	19/01/23
Lee's Pharmaceutical's Q3 Profit More Than Doubles	24/11/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Lee's Pharmaceutical Holdings Limited

Acciones

950

KYG5438W1116

Otros idiomas

Filtros